4//SEC Filing
KELSO INVESTMENT ASSOC V L P 4
Accession 0001209191-05-061318
CIK 0001100962other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:06 PM ET
Size
47.7 KB
Accession
0001209191-05-061318
Insider Transaction Report
Form 4
KELSO INVESTMENT ASSOC V L P
10% Owner
Transactions
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$2.42/sh−627$1,517→ 17,125,727 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$3.00/sh−509$1,527→ 17,122,564 total(indirect: By LLC) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$2.42/sh−2,654$6,423→ 29,478 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (2,654 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$2.42/sh−2,654$6,423→ 17,123,073 total(indirect: By LLC) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$3.00/sh−1,432$4,296→ 279,155 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,432 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$3.00/sh−427$1,281→ 719 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (427 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$2.42/sh−413$999→ 17,128,117 total(indirect: By LLC) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$2.42/sh−1,763$4,266→ 25,896 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,763 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$2.42/sh−5,037$12,190→ 17,128,530 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$3.00/sh−1,432$4,296→ 17,121,131 total(indirect: By LLC) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$2.42/sh−5,037$12,190→ 1,106,424 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (5,037 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$3.00/sh−110$330→ 22,701 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (110 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$2.42/sh−413$999→ 1,266,855 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (413 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$2.42/sh−627$1,517→ 8,870 total(indirect: By LLC)Exercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (627 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-12-02$3.00/sh−509$1,527→ 3,597 total(indirect: By LLC)Exercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (509 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$2.42/sh−1,763$4,266→ 17,126,354 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$3.00/sh−427$1,281→ 17,120,704 total(indirect: By LLC) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-12-02$3.00/sh−110$330→ 17,120,594 total(indirect: By LLC)
Footnotes (3)
- [F1]Kelso Investment Associates V, L.P. (KIA V") is the designated filer.
- [F2]KIA V may be deemed to share beneficial ownership of shares of Common Stock owned of record by Endo Pharma LLC by virtue of its status as a member of Endo Pharma LLC. KIA V shares investment and voting power along with the other members of Endo Pharma LLC with respect to secutieties owned by Endo Pharma LLC, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest.
- [F3]Each individual reporting person may be deemed to share beneficial ownership of shares of Common Stock owned of record by KIA V, by virtue of his status as a general partner of the general partner of KIA V, and each individual shares investment and voting power along with the other general partners of KIA V, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest.
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Entity typeother
Related Parties
1- filerCIK 0001034436
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 9:06 PM ET
- Size
- 47.7 KB